January 14th, 2021 | 18:34 CET
BASF, Bayer, Enapter: From top dogs to young guns
Table of contents:
"[...] We are committed to stay as the number one Canadian and global leader in the Hydrogen-On-Demand diesel technology [...]" Jim Payne, CEO, dynaCERT Inc.
Hydrogen share Enapter: German engineers are turning up the heat
The Enapter share has caused a sensation in recent months. Still trading under the name S&O Beteiligungen, the share has been on a roller coaster ride, bringing many investors quick profits. Enapter has set itself the task of producing green hydrogen using German technology. With its electrolyser, which is modular in design, Enapter wants to produce hydrogen in a climate-neutral way and turn the hydrogen industry around. The goal: to be able to produce hydrogen even more cost-effectively and efficiently. The next generation of the electrolyser is already in development. According to Company sources, the finished product could be presented in the first half of 2021.
Several patents protect Enapter's technology. When asked about the Company's competition, representatives point to the patents and its technological lead, which is between three and five years over the competition. Starting in 2022, the Company wants to ultimately bring its horsepower to the road and mass-produce its electrolyser. It plans to open a factory in North Rhine-Westphalia that will produce up to 100,000 electrolysers a year. Even if the stock still has to be considered a hot potato, the German hydrogen stock with its technological edge is definitely one for the watch list.
BASF wants to become leaner after the Corona year
Investors do not have to remember BASF's name. The stock is an evergreen on the trading floor and has provided generations of private investors with reliable dividends and the odd share price gain. But 2020 was a challenging year for BASF. The pandemic hit the Ludwigshafen-based Company, margins fell and high fixed costs weighed. From a whopping profit in the previous year, BASF plunged to a bitter loss of EUR 2.30 per share after nine months of the fiscal year 2020.
But low figures are no reason for the global corporation to resign. The Company has reviewed its processes and put some areas up for disposal. The Group wants to become leaner and more agile. These measures will pay off in the long term. Although there is little imagination in the stock currently, investors can keep the value in mind, also thanks to the dividend yield of 5% - a watch list is not necessary with BASF.
Bayer: little can shake this big ship
Bayer is just as well-known as BASF. Only two hours further north and also on the Rhine are the Headquarters of the chemical Company. Although Bayer was also affected by the pandemic in 2020, there were only a few write-downs. At least there was some legal progress around the permanent construction site "Monsanto takeover." Like BASF, Bayer is also restructuring but is a few steps further along the way.
The market leader's shares have recovered over the past three months, achieving a return of around 10% in this period. However, the stock is only likely to gain further momentum above the EUR 58 mark. Since Bayer also offers a dividend of around 6%, it is also suitable for long-term investors. With German quality companies such as BASF or Bayer, investors will not make any mistakes even with the DAX around 14,000 points. However, if the portfolio is a little more dynamic, private investors can also add some of the bold challengers to the established top dogs. Thanks to German technology, Enapter is about to become a household name in the field of green hydrogen.
Conflict of interest
Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.
Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.
Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.
The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.